# Efficacy and Safety of Deoxyspergualin in Renal Transplant Patient With Chronic Rejection

> **NCT01052259** · NA · TERMINATED · sponsor: **Nippon Kayaku Co., Ltd.** · enrollment: 35 (actual)

## Conditions studied

- Chronic Rejection

## Interventions

- **DRUG:** Deoxyspergualin

## Key facts

- **NCT ID:** NCT01052259
- **Lead sponsor:** Nippon Kayaku Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-06
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 35 (ACTUAL)
- **Why stopped:** Insufficient patient enrollment
- **Last updated:** 2014-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01052259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01052259, "Efficacy and Safety of Deoxyspergualin in Renal Transplant Patient With Chronic Rejection". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01052259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*